Transposon Therapeutics, Inc.
3 clinical trials · Sponsor
◉ Watch Transposon Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| TPN-101 in Aicardi-Goutières Syndrome (AGS) (NCT05613868) | Transposon Therapeutics, Inc. | 2023-03-15 |
| A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP) (NCT04993768) | Transposon Therapeutics, Inc. | 2021-12-12 |
| A Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTD (NCT04993755) | Transposon Therapeutics, Inc. | 2021-10-01 |
Track Transposon Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.